Vascular Imaging Devices Market Report 2026

Vascular Imaging Devices Market Overview

• Vascular Imaging Devices market size has reached to $8.4 billion in 2025 • Expected to grow to $11.12 billion in 2030 at a compound annual growth rate (CAGR) of 5.8% • Growth Driver: The Increasing Prevalence Of Diabetes And Hypertension Fueling The Growth Of The Market Due To Rising Metabolic And Cardiovascular Health Risks • Market Trend: Development Of Artificial Intelligence Powered Intravascular Ultrasound Platforms By Leading Medical Technology Companies • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Vascular Imaging Devices Market?

Vascular imaging devices are medical equipment that uses non-invasive imaging techniques to see blood vessels and circulatory systems. They utilize various technologies to provide detailed images of the vascular system. It aids in the diagnosis and treatment of cardiovascular problems. The main types of vascular imaging devices are minimally invasive and non-invasive. Minimally invasive procedures involve using small incisions or catheters to access the body's internal structures for diagnostic or therapeutic purposes. The various applications include diagnostics and therapeutics for different end-users, such as hospitals, diagnostic imaging centers, and others.

What Is The Vascular Imaging Devices Market Growth Forecast?

The vascular imaging devices market size is expected to see strong growth in the next few years. It will grow to $11.12 billion in 2030 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to increasing demand for early disease detection, rising investments in advanced imaging technologies, expansion of outpatient diagnostic centers, growing integration of imaging with digital health platforms, development of portable vascular imaging devices. Major trends in the forecast period include increasing integration of ai-based image analysis, rising adoption of non-invasive vascular imaging techniques, growing use of high-resolution imaging modalities, expansion of minimally invasive diagnostic procedures, enhanced focus on early cardiovascular diagnosis.

Global Vascular Imaging Devices Market Segmentation

1) By Type: Minimally Invasive, Non-Invasive 2) By Application: Diagnostics, Therapeutics 3) By End-User: Hospitals, Diagnostic Imaging Centers, Other End Users Subsegments: 1) By Minimally Invasive: Intravascular Ultrasound (IVUS), Optical Coherence Tomography (OCT), Angiography (Including Catheter-Based Angiography) 2) By Non-Invasive: Magnetic Resonance Angiography (MRA), Computed Tomography Angiography (CTA), Doppler Ultrasound, Color Flow Duplex Ultrasound, Contrast-Enhanced Ultrasound, Photoacoustic Imaging

What Is The Driver Of The Vascular Imaging Devices Market?

The increasing prevalence of diabetes and hypertension is expected to propel the growth of the vascular imaging devices market going forward. Diabetes is a chronic metabolic disorder in which the body is unable to produce or effectively use insulin, whereas hypertension is a condition characterized by persistently elevated arterial blood pressure, placing significant strain on the vascular system. The rise in these conditions is driven by aging populations, higher obesity levels, sedentary behaviors, and unhealthy dietary patterns. Vascular imaging enhances clinical management by enabling early detection and continuous monitoring of vascular changes associated with diabetes and hypertension, supporting timely evaluation of disease progression and treatment planning. For instance, in September 2025, according to the World Health Organization, a Switzerland-based international public health agency, 1.4 billion adults aged 30–79 worldwide were living with hypertension in 2024, with only 23% achieving controlled blood pressure. Therefore, the increasing prevalence of diabetes and hypertension is driving the growth of the vascular imaging devices industry.

Key Players In The Global Vascular Imaging Devices Market

Major companies operating in the vascular imaging devices market are Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare Technologies Inc., Terumo Corporation, Nipro Corporation, Shimadzu Corporation, Bracco Group, Carestream Health Inc., Hitachi Medical Corporation, Canon Medical Systems Corporation, Toshiba Medical Systems Corporation, Christie Medical Holdings Inc., Fujifilm Healthcare Corporation, Esaote SpA, Mindray Medical International Limited, Ziehm Imaging GmbH, Samsung Medison Co. Ltd., United Imaging Healthcare

Global Vascular Imaging Devices Market Trends and Insights

Major companies operating in the vascular imaging devices market are focusing on developing next-generation intravascular ultrasound (IVUS) platforms powered by artificial intelligence to overcome the limitations of legacy systems.Next-generation intravascular ultrasound (IVUS) platforms are advanced imaging systems that provide higher-resolution, real-time cross-sectional images of blood vessels to improve diagnosis, guide interventions, and optimize cardiovascular treatments. For instance, in October 2023, Evident Vascular Inc., a US-based med-tech company, officially emerged from stealth with a $35 million Series A financing to build an advanced IVUS platform. This innovation replaces older IVUS systems by providing superior image interpretation, optimized workflow, and better adoption in peripheral vascular interventions, all enabled through AI-based analysis. Backed by Vensana Capital, Evident Vascular’s technology is tailored for vascular interventionalists and is intended initially for peripheral arteries, with future capability in coronary procedures.

What Are Latest Mergers And Acquisitions In The Vascular Imaging Devices Market?

In September 2024, Boston Scientific Corporation, a US-based medical technology company, acquired Silk Road Medical, Inc. for a deal of $1.28 billion. By acquiring Silk Road, Boston Scientific strengthens its offerings in the vascular segment, allowing it to provide comprehensive solutions for physicians treating peripheral vascular diseases. Silk Road Medical's technology allows for minimally invasive procedures, which can reduce recovery times and complications compared to traditional open surgery methods. Silk Road Medical Inc. is a US-based medical device company, specializes in developing and manufacturing devices for the treatment of carotid artery diseases, particularly through its innovative Transcarotid Artery Revascularization (TCAR) platform.

Regional Outlook

North America was the largest region in the vascular imaging devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Vascular Imaging Devices Market?

The vascular imaging devices market consists of sales of angiography systems, intravascular ultrasound systems, high-speed computed tomography systems, and portable doppler devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.